Page 2
2026-11-12 · 2026-11 / week-2
Summary: Digi delivered record Q4 revenue, ARR and adjusted EBITDA, then fell about 14.9% in extended trading after its FY27 outlook. The long rebound case is real, but the company’s guide already includes the pending, d...
2026-11-12 · 2026-11 / week-2
- Research cutoff: November 11, 2026, 21:28 U.S. Eastern time, after the first regular session following results.
2026-11-12 · 2026-11 / week-2
Summary: RUM's first full quarter with Quake AI brought $68.2 million of revenue and positive adjusted EBITDA, but the company still used $113.8 million of operating cash over nine months and reported an $89.9 million Q3...
2026-11-11 · 2026-11 / week-2
Summary: Rackspace has moved beyond an AI memorandum of understanding: it disclosed a multiyear Together AI infrastructure agreement, a separate Blacksmith capacity agreement, and a $66 million stock placement. The Toget...
2026-11-11 · 2026-11 / week-2
Classification: Reject / no trade. Q3 revenue slipped 0.5% year over year, Adjusted EBITDA fell 16%, and GAAP operating income fell 43%. Yet TTD held $1.65B in cash and short-term investments, had $745M of undrawn revolv...
2026-11-11 · 2026-11 / week-2
- Classification: U.S.-listed long screen, Reject / no trade. This is research, not personalized advice.
2026-11-11 · 2026-11 / week-2
Classification: Reject / no trade. CoreWeave reported 168% revenue growth and raised its 2026 revenue and adjusted-operating-income guidance. Yet Q3 operating cash flow less capital expenditure was a derived negative $7....
2026-11-11 · 2026-11 / week-2
- Research cutoff: 10 November 2026, 7:31 p.m. U.S. Eastern time, after the regular session.
2026-11-11 · 2026-11 / week-2
- Research cutoff: 10 November 2026, 12:26 p.m. U.S. Eastern time, during the regular session.
2026-11-11 · 2026-11 / week-2
Summary: Sally Beauty’s FY2027 plan implies about 1.5% sales growth and 1–2% comparable-sales growth. Fourth-quarter free cash flow fell 39.9% year over year, but the next-year guide is only 4.8% below FY2026 while adjus...
2026-11-10 · 2026-11 / week-2
- Research cutoff: 10 November 2026, 07:37 U.S. Eastern time, before the regular session.
2026-11-10 · 2026-11 / week-2
Classification: Reject / no trade. This is a U.S.-listed short screen, not an order or a pending setup.
2026-11-10 · 2026-11 / week-2
Summary: Digital Turbine’s Q2 FY27 revenue grew 27% year over year and adjusted EBITDA grew 46%, but its full-year revenue midpoint rose by $20 million while the adjusted EBITDA range stayed at $145-$155 million. One sec...
2026-11-10 · 2026-11 / week-2
Screen result: Reject / no trade. Hims & Hers cut its 2026 Adjusted EBITDA midpoint by 11% as Q3 gross margin fell to 57%. That is real operating pressure. Yet revenue grew 49%, nine-month free cash flow stayed positive,...
2026-11-10 · 2026-11 / week-2
Summary: Target Hospitality's Q3 revenue grew 30% and adjusted EBITDA grew 59%, while the stock closed at $11.06 on Nov. 9, down 2.6% for the session and about 40% from Oct. 9. Five new multiyear awards create real reven...
2026-11-10 · 2026-11 / week-2
Classification: Reject / no-trade screen. NRG rose about 10.4% on Nov. 9 after reporting strong Q3 results, issuing 2027 guidance, and agreeing to sell 4.9 GW of gas generation for $4 billion. The new guidance explicitly...
2026-11-09 · 2026-11 / week-2
Classification: Reject / no-trade screen. Fastly’s shares fell 26.9% on the first regular session after Q3, despite 20% revenue growth, positive quarterly free cash flow and higher full-year guidance. Q4 guidance implies...
2026-11-09 · 2026-11 / week-2
Summary: Koppers closed at $29.97 on Nov. 6, down 24.4% after Q3 adjusted EBITDA fell 18.2% year over year and FY26 EBITDA guidance fell 9.2% at the midpoint. Free-cash-flow guidance rose, but management tied the improve...
2026-11-09 · 2026-11 / week-2
Classification: Reject / no-trade screen. Berkshire Hathaway’s Q3 insurance-underwriting earnings fell 42.9% year over year, and its Class B shares closed at 1.596 times September book value. But nine-month operating ear...
2026-11-09 · 2026-11 / week-2
Classification: Reject / no-trade screen. Sunstone’s Q3 RevPAR rose 11.4%, Adjusted FFO per diluted share rose 17.6%, and the company raised its FY26 Adjusted FFO/share range. But the $12.52 Nov. 6 reference price alread...